Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
262
datasets available to search
ShareScore release 0.9.0
Dataset results
262 results for “chemokines”
Chemokine Mechanisms in Chronic Pelvic Pain
ClinicalTrials.gov study NCT01676857. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
ClinicalTrials.gov study NCT04504526. IPD Sharing: NO. Countries: 1. Publications: 2.
Urine CXCL10 Chemokine Monitoring Post-renal Transplant
ClinicalTrials.gov study NCT03140514. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
ClinicalTrials.gov study NCT05122182. IPD Sharing: YES. Countries: 1. Publications: 1.
The Influence of Two Different Hepatectomy Methods on Transection Speed and Chemokine Release From the Liver
ClinicalTrials.gov study NCT01785212. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Colonic cytokines and chemokines in DNBS colitis
Open the record for dataset details and reuse information.
Data from: Vascular disease in COPD: systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)
Introduction. The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology of Chronic Obstructive Pulmonary Disease (COPD) is not fully understood. The aim of the present study is to analyze the expression of PARC in lung tissue and its relationship with the vascular remodeling of the systemic and pulmonary arteries of COPD subjects. Methods. To achieve this objective, protein and gene expression experiments, together with ELISA assays, were performed on the lung tissue, intercostal arteries and serum samples from COPD patients, non-obstructed smokers (NOS) and never-smokers (NS). Results. A total of 57 subjects were included in the analysis (23 COPD, 18 NOS and 16 NS). In the comparisons between groups, a significantly increased lung protein expression of PARC was observed in the COPD group compared to the NOS group (1.96±0.22 vs. 1.29±0.27, P-adjusted=0.038). PARC was located predominantly in the smooth muscle cells of the remodeled pulmonary muscular arteries and the macrophage-rich area of the alveolar parenchyma. No differences were detected in PARC gene expression analyses. The protein content of PARC in the intercostal arteries were similar between groups, though little remodeling was observed in these arteries. Circulating levels of PARC were numerically higher in patients with COPD compared to NOS and NS. Conclusion. The results of the present study suggest an increased lung protein expression of PARC in COPD subjects. This protein was mainly localized in the smooth muscle cells of the pulmonary muscular arteries and was associated with the severity of intimal thickening, indicating its possible role in this remodeling process.
Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04081389. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
ClinicalTrials.gov study NCT03838367. IPD Sharing: NO. Countries: 1. Publications: 0.
The Relationship Between Serum Chemokine Ligand 21 (CCL-21) Level and Disease Activity
ClinicalTrials.gov study NCT06540573. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects
ClinicalTrials.gov study NCT00197145. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy
ClinicalTrials.gov study NCT01712061. IPD Sharing: Not stated. Countries: 14. Publications: 0.
αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
ClinicalTrials.gov study NCT02151448. IPD Sharing: NO. Countries: 1. Publications: 0.
Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer
ClinicalTrials.gov study NCT01545141. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes
ClinicalTrials.gov study NCT02134717. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer
ClinicalTrials.gov study NCT00992186. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Chemokine (CXCL13) as Anew Marker in Diagnosis of SLE
ClinicalTrials.gov study NCT03752983. IPD Sharing: NO. Countries: 0. Publications: 1.
Role of Thymus-And Activation-Regulated Chemokine (TARC) In Diagnosis Of Allergic Bronchopulmonary Aspergillosis
ClinicalTrials.gov study NCT03267394. IPD Sharing: Not stated. Countries: 0. Publications: 1.
C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03150849. IPD Sharing: NO. Countries: 0. Publications: 7.
Fingolimod Effect on Cytokine and Chemokine Levels
ClinicalTrials.gov study NCT02373098. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.